157 related articles for article (PubMed ID: 37073632)
1. Perspectives of opioid prescribers in overdose hotspots and coldspots, Massachusetts, 2019.
Santelices C; Pustz J; Chase C; Kim JY; Stopka TJ
Subst Use Misuse; 2023; 58(8):1069-1074. PubMed ID: 37073632
[TBL] [Abstract][Full Text] [Related]
2. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
[TBL] [Abstract][Full Text] [Related]
3. "1,000 conversations I'd rather have than that one:" A qualitative study of prescriber experiences with opioids and the impact of a prescription drug monitoring program.
Zavodnick J; Wickersham A; Petok A; Worster B; Leader A
J Addict Dis; 2022; 40(4):527-537. PubMed ID: 35133217
[TBL] [Abstract][Full Text] [Related]
4. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
5. Opioid overdose deaths and potentially inappropriate opioid prescribing practices (PIP): A spatial epidemiological study.
Stopka TJ; Amaravadi H; Kaplan AR; Hoh R; Bernson D; Chui KKH; Land T; Walley AY; LaRochelle MR; Rose AJ
Int J Drug Policy; 2019 Jun; 68():37-45. PubMed ID: 30981166
[TBL] [Abstract][Full Text] [Related]
6. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
[TBL] [Abstract][Full Text] [Related]
7. The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis.
Dickson-Gomez J; Krechel S; Spector A; Weeks M; Ohlrich J; Green Montaque HD; Li J
Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):55. PubMed ID: 35864522
[TBL] [Abstract][Full Text] [Related]
8. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
[TBL] [Abstract][Full Text] [Related]
9. The effect of a statewide prescription drug monitoring program on opioid prescribing patterns.
Rubin SJ; Wang JJ; Nodoushani AY; Yarlagadda BB; Wulu JA; Edwards HA
Am J Otolaryngol; 2022; 43(1):103262. PubMed ID: 34626913
[TBL] [Abstract][Full Text] [Related]
10. Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018.
Henry SG; Shev AB; Crow D; Stewart SL; Wintemute GJ; Fenlon C; Wirtz SJ
Prev Med; 2021 Dec; 153():106861. PubMed ID: 34687731
[TBL] [Abstract][Full Text] [Related]
11. "Nobody Knows How You're Supposed to Interpret it:" End-user Perspectives on Prescription Drug Monitoring Program in Massachusetts.
Hong M; Seymour S; Stopka TJ; Bandanza L; Crocker E; Morgan A; Beletsky L
J Addict Med; 2022 May-Jun 01; 16(3):e171-e176. PubMed ID: 34417413
[TBL] [Abstract][Full Text] [Related]
12. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
[TBL] [Abstract][Full Text] [Related]
13. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
Brown WC; Whitted K
J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
[TBL] [Abstract][Full Text] [Related]
14. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
[TBL] [Abstract][Full Text] [Related]
15. Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.
Perrone J; DeRoos FJ; Nelson LS
J Med Toxicol; 2012 Dec; 8(4):341-52. PubMed ID: 22895794
[TBL] [Abstract][Full Text] [Related]
16. The effects of state rules on opioid prescribing in Indiana.
Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
[TBL] [Abstract][Full Text] [Related]
17. Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults.
Toce MS; Michelson KA; Hudgins JD; Hadland SE; Olson KL; Monuteaux MC; Bourgeois FT
Ann Emerg Med; 2023 Apr; 81(4):429-437. PubMed ID: 36669914
[TBL] [Abstract][Full Text] [Related]
18. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
[TBL] [Abstract][Full Text] [Related]
19. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
[TBL] [Abstract][Full Text] [Related]
20. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
Fink PB; Deyo RA; Hallvik SE; Hildebran C
Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
